Targeted prostate cancer screening in men with mutations in <i>BRCA1</i> and <i>BRCA2</i> detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
Anita Mitra(West Hertfordshire Hospitals NHS Trust), Alison Falconer(Imperial College Healthcare NHS Trust), Graeme Suthers(The University of Adelaide), Barbara Bulman(Manchester Academic Health Science Centre), Rebecca Doherty(Peter MacCallum Cancer Centre), Teresa Ramón y Cajal(Hospital de Sant Pau), Gillian Douglas(Institute of Genetics and Cancer), Irene Jobson(Institute of Genetics and Cancer), Sharron Townshend(King Edward Memorial Hospital), Eitan Friedman(University of Pennsylvania), Barbara Newcombe(Addenbrooke's Hospital), Soo‐Hwang Teo(Cancer Research Malaysia), Palle Jørn Sloth Osther(University of Southern Denmark), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Andrew J. Stapleton(Flinders University), Lyndon Walker(Churchill Hospital), Audrey Ardern‐Jones(Royal Marsden NHS Foundation Trust), Susan M. Domchek(University City Science Center), Wendy S. Rubinstein(National Cancer Institute), Allan D. Spigelman(Cancer Institute of New South Wales), Nicola Nicolai(Fondazione IRCCS Istituto Nazionale dei Tumori), Charles Jameson(Royal London Hospital), Saundra S. Buys(University of Utah), Ignacio Blanco(Hospital Universitari Germans Trias i Pujol), Geoffrey J. Lindeman(The University of Melbourne), Lovise Mæhle(Unknown), Huw Dorkins(London North West Healthcare NHS Trust), Alison Male(Great Ormond Street Hospital), D. Gareth Evans(Manchester Academic Health Science Centre), Neil K. Aaronson(The Netherlands Cancer Institute), Katherine Tucker(Prince of Wales Hospital), Yolanda Barbáchano(Royal Marsden NHS Foundation Trust), Christopher S. Foster(Institute of Cancer Research), Virginia Clowes(London North West Healthcare NHS Trust), Alan Donaldson(University Hospitals Bristol NHS Foundation Trust), David Dearnaley(Royal Marsden NHS Foundation Trust), Chris Bangma(Erasmus MC), Judy Kirk(Westmead Hospital), Cezary Cybulski(Kolding Hospital), Catherine Mercer, C Brewer(Royal Devon and Exeter Hospital), Gillian Mitchell(Peter MacCallum Cancer Centre), Elizabeth Page(Institute of Cancer Research), D. G. Crüger(Vejle Sygehus), Jórunn E. Eyfjörd(Institute of Cancer Research), Shirley Hodgson(St Thomas' Hospital), Mónica Salinas(Institut d'Investigació Biomédica de Bellvitge), Elizabeth Bancroft(Royal Marsden NHS Foundation Trust), Diana Eccles(Princess Anne Hospital), Karol Axcrona(Norwegian Cancer Society)
Cited by 98
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k